Characterization of a Tumor-Microenvironment-Relevant Gene Set Based on Tumor Severity in Colon Cancer and Evaluation of Its Potential for Dihydroartemisinin Targeting
Open Access
- 17 June 2021
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-10
Abstract
Colon cancer (COAD) is a leading cause of cancer mortality in the world. Most patients with COAD die as a result of cancer cell metastasis. However, the mechanisms underlying the metastatic phenotype of COAD remain unclear. Instead, particular features of the tumor microenvironment (TME) could predict adverse outcomes including metastasis in patients with COAD, and the role of TME in governing COAD progression is undeniable. Therefore, exploring the role of TME in COAD may help us better understand the molecular mechanisms behind COAD progression which may improve clinical outcomes and quality of patients. Here, we identified a Specific TME Regulatory Network including AEBP1, BGN, POST, and FAP (STMERN) that is highly involved in clinical outcomes of patients with COAD. Comprehensive in silico analysis of our study revealed that the STMERN is highly correlated with the severity of COAD. Meanwhile, our results reveal that the STMERN might be associated with immune infiltration in COAD. Importantly, we show that dihydroartemisinin (DHA) potentially interacts with the STMERN. We suggest that DHA might contribute to immune infiltration through regulating the STMERN in COAD. Taken together, our data provide a set of biomarkers of progression and poor prognosis in COAD. These findings could have potential prognostic and therapeutic implications in the progression of COAD.Keywords
Funding Information
- Sanming Project of Medicine in Shenzen Municipality (SZSM201612021)
This publication has 42 references indexed in Scilit:
- Cancer cells induce metastasis-supporting neutrophil extracellular DNA trapsScience Translational Medicine, 2016
- Comprehensive analyses of tumor immunity: implications for cancer immunotherapyGenome Biology, 2016
- Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancersNature Medicine, 2016
- Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus OxaliplatinJournal of Clinical Oncology, 2013
- Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivoBiochemical Pharmacology, 2012
- Perspectives on Current Tumor-Node-Metastasis (TNM) Staging of Cancers of the Colon and RectumSeminars in Oncology, 2011
- Dihydroartemisinin shift the immune response towards Th1, inhibit the tumor growth in vitro and in vivoCellular Immunology, 2011
- Long-Term Survival Results of Surgery Alone Versus Surgery Plus 5-Fluorouracil and Leucovorin for Stage II and Stage III Colon Cancer: Pooled Analysis of NSABP C-01 Through C-05. A Baseline from Which to Compare Modern Adjuvant TrialsAnnals of Surgical Oncology, 2010
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- The crystal structure of human deoxyhaemoglobin at 1.74 Å resolutionJournal of Molecular Biology, 1984